We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 139% below its sector, cheaper than its peers on earnings.
Vuno Inc. specializes in developing artificial intelligence solutions for the medical industry. The company's AI-driven offerings are designed to analyze diverse medical data, providing crucial assistance in diagnosing various diseases. Its comprehensive product suite includes BoneAge, an AI software for assessing bone age; DeepBrain, a quantitative brain parcellation tool for analyzing neurodegenerative and other neurological conditions; an AI-powered diagnostic support system for detecting abnormalities in chest X-rays; Fundus AI, an AI-based screening solution for retinal irregularities; and LungCT AI, which focuses on detecting and reporting pulmonary lung nodules. Established in 2014, the company is headquartered in Seoul, South Korea.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 338220.KQ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
